Ipragliflozin: A novel sodium-glucose cotransporter 2 inhibitor developed in Japan.
about
Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study.Rationale and design of a multicenter randomized controlled study to evaluate the preventive effect of ipragliflozin on carotid atherosclerosis: the PROTECT study.The potential of SGLT2 inhibitors in phase II clinical development for treating type 2 diabetes.A concise and practical stereoselective synthesis of ipragliflozin L-proline.Glycemic Control with Ipragliflozin, a Novel Selective SGLT2 Inhibitor, Ameliorated Endothelial Dysfunction in Streptozotocin-Induced Diabetic MousePharmacotherapy with Thymoquinone Improved Pancreatic β-Cell Integrity and Functional Activity, Enhanced Islets Revascularization, and Alleviated Metabolic and Hepato-Renal Disturbances in Streptozotocin-Induced Diabetes in Rats.Effect of 24-week treatment with ipragliflozin on proinsulin/C-peptide ratio in Japanese patients with type 2 diabetes.
P2860
Q36429733-B242EB00-FC9F-4E18-BC1B-2DBFF03CB980Q37251449-EDA70577-F7F3-42A1-8A17-528AD9E0BBD2Q38908779-622F162F-A4D0-4C48-9DF5-5C58305EDC11Q41070264-B638AF45-B2BF-4DA0-93A4-9E4D208EA51BQ41579741-6248ECC8-A384-4C9E-B597-3F53FD42E1CFQ47778694-BA2C59ED-F478-413E-951B-FB6F87A95B31Q51276351-67A4D4F5-0830-440C-9593-B2C41E68CC3C
P2860
Ipragliflozin: A novel sodium-glucose cotransporter 2 inhibitor developed in Japan.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Ipragliflozin: A novel sodium-glucose cotransporter 2 inhibitor developed in Japan.
@ast
Ipragliflozin: A novel sodium-glucose cotransporter 2 inhibitor developed in Japan.
@en
type
label
Ipragliflozin: A novel sodium-glucose cotransporter 2 inhibitor developed in Japan.
@ast
Ipragliflozin: A novel sodium-glucose cotransporter 2 inhibitor developed in Japan.
@en
prefLabel
Ipragliflozin: A novel sodium-glucose cotransporter 2 inhibitor developed in Japan.
@ast
Ipragliflozin: A novel sodium-glucose cotransporter 2 inhibitor developed in Japan.
@en
P2860
P356
P1476
Ipragliflozin: A novel sodium-glucose cotransporter 2 inhibitor developed in Japan.
@en
P2093
Tsuyoshi Ohkura
P2860
P304
P356
10.4239/WJD.V6.I1.136
P577
2015-02-01T00:00:00Z